$CLOV News

Clover Health's Bullish Setup Still Looks Compelling

A Look At Clover Health (CLOV) Valuation After Profitability Return And Medicare Advantage Growth

Clover Health (CLOV) Q1 2026 Earnings Transcript

Clover Health Investments, Corp. (CLOV) Q1 2026 Earnings Call Transcript

Clover Health Investments, Corp. Q1 2026 Earnings Call Summary

Clover Health Investments Q1 Earnings Call Highlights

Clover Health Investments, Corp. 2026 Q1 - Results - Earnings Call Presentation

Clover Health Investments (NASDAQ:CLOV) Q1 Beat Fails to Inspire After-Hours

Clover Health Investments, Corp. (CLOV) Meets Q1 Earnings Estimates

Clover Health (NASDAQ:CLOV) Surprises With Strong Q1 CY2026

Clover Health Reports First Quarter 2026 Results

Clover Health Investments Affirms FY2026 Sales Guidance of $2.810B-$2.920B vs $2.878B Est

Clover Health Investments Q1 EPS $0.05 Beats $0.03 Estimate, Sales $749.200M Beat $714.893M Estimate

Clover Health Investments CFO Peter Kuipers Steps Down, Effective March 30; Clay Thornton Appointed Interim Successor

Canaccord Genuity Maintains Buy on Clover Health Investments, Lowers Price Target to $3.2

Clover Health's Subsidiary Publishes Whitepaper on "Driving Clinical Excellence in Chronic Disease" Highlighting Use of Counterpart Assistant Associated With 18%–22% Fewer Flu-Related Acute Care Events Among COPD And CHF Patients

Clover Health: Strong Growth, Improving Margins, And A Mispriced Stock

UPDATED – Moving from Pledge to Production, Clover Health is Now Live on Kno2, Participating in Recently Announced Federal Interoperability Initiatives

Clover Health (CLOV) Valuation Check After TEFCA Milestone And Profitability Guidance

Clover Health Enters Collaboration to Be Part of CMS Aligned Network